Airedale General Hospital is an NHS district General Hospital based in Steeton with Eastburn, West Yorkshire, England and is operated by the Airedale NHS Foundation Trust. Airedale was opened for patients in July 1970 and officially opened by the Prince of Wales on 11 December of the same year.

There are 324 beds in Airedale General Hospital.

During the past decade, Airedale General Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Airedale General Hospital" #1 sponsor was "University College, London" with 3 trials, followed by "University of Leeds" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Institute of Cancer Research, United Kingdom" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Airedale General Hospital" #1 collaborator was "University of Oxford" with 2 trials as a collaborator, "Academic Medical Organization of Southwestern Ontario" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Cancer Research UK" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Airedale General Hospital" are "Breast Cancer" (6 trials), "Colorectal Cancer" (4 trials), "Fallopian Tube Cancer" (3 trials), "Ovarian Cancer" (3 trials) and "Primary Peritoneal Cavity Cancer" (3 trials). Many other conditions were trialed in "Airedale General Hospital" in a lesser frequency.

Most popular intervention types in "Airedale General Hospital" are "Drug" (19 trials), "Biological" (6 trials), "Other" (5 trials), "Procedure" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (3 trials), "quality-of-life assessment" (3 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "Airedale General Hospital" are 20 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Airedale General Hospital". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Airedale General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Airedale General Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".